Abstract
Canada Cardiovascular Devices Market Analysis and Forecasts to 2015
Summary
GlobalData’s medical device report: “Canada Cardiovascular Devices
Market Analysis and Forecasts to 2015” report provides key data,
information and analysis on the Canada cardiovascular devices market. The
report provides market landscape, competitive landscape and market trends
information on seven market categories including cardiac rhythm management,
cardiovascular monitoring and diagnostic devices, cardiovascular prosthetic
devices, cardiovascular surgery, interventional cardiology, peripheral
vascular devices and electrophysiology. The report provides comprehensive
information on the key trends affecting these categories, and key analytical
insight on the market dynamics. The report also reviews the competitive
landscape in terms of mergers and acquisitions, pipeline products and
technology offerings.
Scope
- Forecasts & Analysis of the Canada cardiovascular devices market to
2015.
- Market segmentation by Cardiac Rhythm Management (CRM),
Cardiovascular Monitoring and Diagnostic Devices, Cardiovascular Prosthetic
Devices, Cardiovascular Surgery, Interventional Cardiology, Peripheral
Vascular Devices and Electrophysiology.
- Market Analysis from 2001 to
2008, including new updated 2008 data.
- Analysis of the leading companies
and competitive landscape including 2008 company market share analysis.
-
Analysis of key diabetes care pipeline products, new technologies and clinical
trials.
- Insight into the key mergers and acquisitions (M&As),
partnerships, venture capital and private equity investments.
-
Qualitative analysis of market drivers, market limiters regulatory issues and
future outlook.
Reasons to buy
- Understand what the new growth opportunities are within the Canada
cardiovascular devices market.
- Develop a clear knowledge & understanding
of the Canada cardiovascular devices competitor landscape and how this will
change to 2015.
- Identify acquisition opportunities across the Canada
cardiovascular devices market.
- Identify key winners and losers and who
is best positioned to take advantage of the emerging market opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying
products, most likely to ensure a robust return.
- Make more informed
business decisions from the insightful and in-depth analysis of the market and
the factors shaping it.
Keywords
Canada health structure, drug eluting stent, catheters, tissue valve,
mechanical valve, heart valve, cardiac assist, peripheral vascular devices,
cardiac rhythm management, pacemakers, implantable defibrillators, average
price, market size, competitive analysis, company share, market share, average
price, pipeline products, drivers, restraints, volume, Boston Scientific
Corporation, Medtronic, Inc., Cordis Corporation, Abbott Laboratories, St.
Jude Medical Inc., BIOTRONIK GmbH & Co. KG, Sorin Group Canada, Inc., GE
Healthcare, Philips Healthcare, OSI Systems, Inc., Cardiac Science
Corporation, Nihon Kohden Corporation, Welch Allyn Inc., Card Guard AG,
Edwards Lifesciences Corporation, Thoratec Corporation, Datascope
Corporation, Arrow International, Inc., ABIOMED, Inc., MAQUET GmbH & Co.
KG, AtriCure, Inc., Terumo Corporation, ev3 Inc., C.R. Bard, Inc.,
Medical Ventures Corp., Baylis Medical Company Inc., Interface Biologics,
Inc., Kardium Inc., CARDIAnove.
Table of Contents
1 Table of Contents 2
1.1 List of Tables 8
1.2 List of Figures 13
2 Introduction 16
2.1 What Is This Report About? 16
3 Executive
Summary 17
4 Definitions of the Markets Covered in the Report 18
4.1
Cardiovascular Devices 18
4.2 Cardiac Rhythm Management 18
4.3
Cardiovascular monitoring and diagnostic devices 19
4.4 Cardiovascular
prosthetic device 20
4.5 Cardiovascular Surgery 21
4.6
Electrophysiology 22
4.7 Interventional cardiology 22
4.8 Peripheral
vascular devices 24
5 Healthcare Sector Review 25
5.1 Healthcare
Expenditure 25
5.2 Healthcare Infrastructure 28
5.3 Healthcare Policy
31
5.4 Canada Healthcare Trade Statistics 32
6 Regulation System
33
6.1 Medical Equipment Approval Process 33
6.2 Labeling and
Packaging 36
6.3 Post-Market Surveillance 36
7 Pricing and
Reimbursement 37
8 Distribution Structure 38
8.1 Distribution
Structure 38
9 Cardiovascular Devices In Canada 39
9.1 Cardiovascular
Devices, Canada, Overall Revenue ($ m), 2000-2015 39
9.2 Cardiovascular
Devices, Canada, Category Volume (Units), 2000-2015 43
9.3 Cardiovascular
Devices Market Canada Cross Category Analysis 47
9.4 Cardiovascular
Devices, Canada, Company Share (2007-2008) 49
10 Cardiac Rhythm Management
In Canada 50
10.1 Cardiac Rhythm Management Overall Revenue (2000-2015)
50
10.2 Cardiac Rhythm Management Overall Volume (2000-2015) 60
10.3
Cardiac Rhythm Management Market Dynamics 68
10.4 Cardiac Rhythm
Management Average Price (2000-2015) 69
10.5 Cardiac Rhythm Management
Distribution Share (2007-2008) 70
10.6 Cardiac Rhythm Management, Canada,
Company Share (2007-2008) 71
11 Cardiovascular Monitoring and Diagnostic
Devices In Canada 72
11.1 Cardiovascular Monitoring and Diagnostic Devices
Overall Revenue (2000-2015) 72
11.2 Cardiovascular Monitoring and
Diagnostic Devices Overall Volume (2000-2015) 76
11.3 Cardiovascular
Monitoring & Diagnostic Devices Market Dynamics 78
11.4 Cardiovascular
Monitoring and Diagnostic Devices Average Price (2000-2015) 79
11.5
Cardiovascular Monitoring and Diagnostic Devices Distribution Share
(2007-2008) 80
11.6 Cardiovascular Monitoring and Diagnostic Devices,
Canada, Company Share (2007-2008) 81
12 Cardiovascular Prosthetic Devices
In Canada 82
12.1 Cardiovascular Prosthetic Devices Overall Revenue
(2000-2015) 82
12.2 Cardiovascular Prosthetic Devices Overall Volume
(2000-2015) 90
12.3 Cardiovascular Prosthetic Devices Market Dynamics
96
12.4 Cardiovascular Prosthetic Devices Average Price (2000-2015) 96
12.5 Cardiovascular Prosthetic Devices Distribution Share (2007-2008) 97
12.6 Cardiovascular Prosthetic Devices, Canada, Company Share (2007-2008)
98
13 Cardiovascular Surgery In Canada 99
13.1 Cardiovascular Surgery
Overall Revenue (2000-2015) 99
13.2 Cardiovascular Surgery Overall Volume
(2000-2015) 103
13.3 Cardiovascular Surgery Market Dynamics 106
13.4
Cardiovascular Surgery Average Price (2000-2015) 107
13.5 Cardiovascular
Surgery Distribution Share (2007-2008) 108
13.6 Cardiovascular Surgery,
Canada, Company Share (2007-2008) 109
14 Electrophysiology in Canada
110
14.1 Electrophysiology Overall Revenue (2000-2015) 110
14.2
Electrophysiology Overall Volume (2000-2015) 112
14.3 Electrophysiology
Market Dynamics 113
14.4 Electrophysiology Average Price (2000-2015)
113
14.5 Electrophysiology Distribution Share (2007-2008) 114
14.6
Electrophysiology, Canada, Company Share (2007-2008) 115
15 Interventional
Cardiology In Canada 116
15.1 Interventional Cardiology Overall Revenue
(2000-2015) 116
15.2 Interventional Cardiology Overall Volume (2000-2015)
126
15.3 Interventional Cardiology Market Dynamics 134
15.4
Interventional Cardiology Average Price (2000-2015) 135
15.5
Interventional Cardiology Distribution Share (2007-2008) 136
15.6
Interventional Cardiology, Canada, Company Share (2007-2008) 137
16
Peripheral Vascular Devices In Canada 138
16.1 Peripheral Vascular Devices
Overall Revenue (2000-2015) 138
16.2 Peripheral Vascular Devices Overall
Volume (2000-2015) 142
16.3 Peripheral Vascular Devices Market Dynamics
146
16.4 Peripheral Vascular Devices Average Price (2000-2015) 147
16.5 Peripheral Vascular Devices Distribution Share (2007-2008) 148
16.6
Peripheral Vascular Devices, Canada, Company Share (2007-2008) 149
17
Overview of Key Companies in Canada Cardiovascular Devices Market 150
17.1
Boston Scientific Corporation 150
17.2 Medtronic, Inc. 159
17.3 Cordis
Corporation 167
17.4 Abbott Laboratories 170
17.5 St. Jude Medical
Inc. 172
17.6 BIOTRONIK GmbH & Co. KG 178
17.7 Sorin Group Canada,
Inc. 180
17.8 GE Healthcare 180
17.9 Philips Healthcare 180
17.10
OSI Systems, Inc. 186
17.11 Cardiac Science Corporation 188
17.12
Nihon Kohden Corporation 191
17.13 Welch Allyn Inc. 193
17.14 Card
Guard AG 193
17.15 Edwards Lifesciences Corporation 194
17.16 Thoratec
Corporation 199
17.17 Datascope Corporation 203
17.18 Arrow
International, Inc. 206
17.19 ABIOMED, Inc. 210
17.20 MAQUET GmbH &
Co. KG 214
17.21 AtriCure, Inc. 214
17.22 Terumo Corporation 216
17.23 ev3 Inc. 220
17.24 C.R. Bard, Inc. 225
17.25 Medical Ventures
Corp. 229
17.26 Baylis Medical Company Inc. 229
17.27 Interface
Biologics, Inc. 229
17.28 Kardium Inc. 232
17.29 CARDIAnove 233
18
Financial Deals Landscape 234
18.1 Partnerships 234
19 Recent
Developments 236
19.1 Strategy And Business Planning 236
19.2 Product
News 237
20 Appendix 238
20.1 GlobalData Research Methodology 238
20.2 Coverage 239
20.3 Secondary Research 240
20.4 Primary Research
240
20.5 Models 241
20.6 Forecasts 241
20.7 Expert Panel
Validation 242
20.8 Currency Conversion 243
20.9 Contact Us 244
20.10 Disclaimer 244
1.1 List of Tables
Table 1: Number of
Physicians by Province in Canada, 2001 and 2005 35
Table 2: Hospital Wards
by Specialty in Canada, 2003-2007 36
Table 3: Doctors by Specialty in
Canada, 2003-2007 37
Table 4: Canada Healthcare Trade Statistics,
2001-2006 39
Table 5: Medical Equipment Classification in Canada, 2007
40
Table 6: Medical Equipment Licensing Fee in Canada, 2007 42
Table
7: Medical Equipment License Processing Duration in Canada, 2007 42
Table
8: Cardiovascular Devices, Canada, Overall Revenue ($ m), Historic,
2000-2008 47
Table 9: Cardiovascular Devices, Canada, Overall Revenue
($ m), Forecast, 2008-2015 49
Table 10: Cardiovascular Devices,
Canada, Category Volume (Units), Historic, 2000-2008 51
Table 11:
Cardiovascular Devices, Canada, Category Volume (Units), Forecast, 2008-2015
52
Table 12: Cardiovascular Devices, Canada, Cross-Category Analysis,
2000-2015 54
Table 13: Cardiovascular Devices, Canada, Company Share
by Revenue ($ m), 2007-2008 56
Table 14: Cardiac Rhythm Management,
Canada, Revenue ($ m) by Segment, Historic, 2000-2008 57
Table 15:
Cardiac Rhythm Management, Canada, Revenue ($ m) by Segment, Forecast,
2008-2015 59
Table 16: Cardiac Resynchronisation Therapy, Canada,
Revenue ($ m) by Sub-Segment, Historic, 2000-2008 60
Table 17:
Cardiac Resynchronisation Therapy, Canada, Revenue ($ m) by Sub-Segment,
Forecast, 2008-2015 61
Table 18: Implantable Cardioverter
Defibrillator, Canada, Revenue ($ m) by Sub-Segment, Historic, 2000-2008
63
Table 19: Implantable Cardioverter Defibrillator, Canada, Revenue
($ m) by Sub-Segment, Forecast, 2008-2015 64
Table 20: Pacemaker,
Canada, Revenue ($ m) by Sub-Segment, Historic, 2000-2008 65
Table 21:
Pacemaker, Canada, Revenue ($ m) by Sub-Segment, Forecast, 2008-2015 66
Table 22: Cardiac Rhythm Management, Canada, Volume (Units) by Segment,
Historic, 2000-2008 67
Table 23: Cardiac Rhythm Management, Canada,
Volume (Units) by Segment, Forecast, 2008-2015 68
Table 24: Cardiac
Resynchronisation Therapy, Canada, Volume (Units) by Sub-Segment, Historic,
2000-2008 69
Table 25: Cardiac Resynchronisation Therapy, Canada,
Volume (Units) by Sub-Segment, Historic, 2000-2008 70
Table 26:
Implantable Cardioverter Defibrillator, Canada, Volume (Units) by Sub-Segment,
Forecast, 2008-2015 71
Table 27: Implantable Cardioverter
Defibrillator, Canada, Volume (Units) by Sub-Segment, Historic, 2000-2008
72
Table 28: Pacemaker, Canada, Volume (Units) by Sub-Segment,
Forecast, 2008-2015 73
Table 29: Pacemaker, Canada, Volume (Units) by
Sub-Segment, Forecast, 2008-2015 74
Table 30: Cardiac Rhythm
Management, Canada, Average Price ($), Historic, 2000-2008 76
Table 31:
Cardiac Rhythm Management, Canada, Average Price ($), Forecast, 2008-2015
76
Table 32: Cardiac Rhythm Management, Canada, Distribution Share by
Revenue ($mn), 2007-2008 77
Table 33: Cardiac Rhythm Management,
Canada, Company Share by Revenue ($ m), 2007-2008 78
Table 34:
Cardiovascular Monitoring and Diagnostic Devices, Canada, Revenue ($ m) by
Segment, Historic, 2000-2008 80
Table 35: Cardiovascular Monitoring
and Diagnostic Devices, Canada, Revenue ($ m) by Segment, Forecast, 2008-2015
81
Table 36: Cardiovascular Monitoring and Diagnostic Devices,
Canada, Volume (Units) by Segment, Historic, 2000-2008 83
Table 37:
Cardiovascular Monitoring and Diagnostic Devices, Canada, Volume (Units) by
Segment, Forecast, 2008-2015 84
Table 38: Cardiovascular Monitoring
and Diagnostic Devices, Canada, Average Price ($), Historic, 2000-2008 86
Table 39: Cardiovascular Monitoring and Diagnostic Devices, Canada,
Average Price ($), Forecast, 2008-2015 86
Table 40: Cardiovascular
Monitoring and Diagnostic Devices, Canada, Distribution Share by Revenue ($m),
2007-2008 87
Table 41: Cardiovascular Monitoring and Diagnostic
Devices, Canada, Company Share by Revenue ($ m), 2007-2008 88
Table 42:
Cardiovascular Prosthetic Devices, Canada, Revenue ($ m) by Segment,
Historic, 2000-2008 90
Table 43: Cardiovascular Prosthetic Devices,
Canada, Revenue ($ m) by Segment, Forecast, 2008-2015 91
Table 44:
Cardiac Assist Devices, Canada, Revenue ($ m) by Sub-Segment, Historic,
2000-2008 93
Table 45: Cardiac Assist Devices, Canada, Revenue ($ m)
by Sub-Segment, Forecast, 2008-2015 94
Table 46: Prosthetic Heart
Valve, Canada, Revenue ($ m) by Sub-Segment, Historic, 2000-2008 95
Table
47: Prosthetic Heart Valve, Canada, Revenue ($ m) by Sub-Segment,
Forecast, 2008-2015 96
Table 48: Cardiovascular Prosthetic Devices,
Canada, Volume (Units) by Segment, Historic, 2000-2008 97
Table 49:
Cardiovascular Prosthetic Devices, Canada, Volume (Units) by Segment,
Forecast, 2008-2015 98
Table 50: Cardiac Assist Devices, Canada,
Volume (Units) by Sub-Segment, Historic, 2000-2008 99
Table 51:
Cardiac Assist Devices, Canada, Volume (Units) by Sub-Segment, Forecast,
2008-2015 100
Table 52: Prosthetic Heart Valve, Canada, Volume
(Units) by Sub-Segment, Historic, 2000-2008 101
Table 53: Prosthetic
Heart Valve, Canada, Volume (Units) by Sub-Segment, Forecast, 2008-2015
102
Table 54: Cardiovascular Prosthetic Devices, Canada, Average
Price ($), Historic, 2000-2008 103
Table 55: Cardiovascular
Prosthetic Devices, Canada, Average Price ($), Forecast, 2008-2015 104
Table 56: Cardiovascular Prosthetic Devices, Canada, Distribution Share
by Revenue ($m), 2007-2008 104
Table 57: Cardiovascular Prosthetic
Devices, Canada, Company Share by Revenue ($ m), 2007-2008 105
Table 58:
Cardiovascular Surgery, Canada, Revenue ($ m) by Segment, Historic,
2000-2008 106
Table 59: Cardiovascular Surgery, Canada, Revenue ($ m)
by Segment, Forecast, 2008-2015 107
Table 60: Perfusion Disposables,
Canada, Revenue ($ m) by Sub-Segment, Historic, 2000-2008 108
Table 61:
Perfusion Disposables, Canada, Revenue ($ m) by Sub-Segment, Forecast,
2008-2015 109
Table 62: Cardiovascular Surgery, Canada, Volume
(Units) by Segment, Historic, 2000-2008 110
Table 63: Cardiovascular
Surgery, Canada, Volume (Units) by Segment, Forecast, 2008-2015 110
Table
64: Perfusion Disposables, Canada, Volume (Units) by Sub-Segment,
Historic, 2000-2008 111
Table 65: Perfusion Disposables, Canada,
Volume (Units) by Sub-Segment, Forecast, 2008-2015 112
Table 66:
Cardiovascular Surgery, Canada, Average Price ($), Historic, 2000-2008 114
Table 67: Cardiovascular Surgery, Canada, Average Price ($), Forecast,
2008-2015 114
Table 68: Cardiovascular Surgery, Canada, Distribution
Share by Revenue ($m), 2007-2008 115
Table 69: Cardiovascular
Surgery, Canada, Company Share by Revenue ($ m), 2007-2008 116
Table 70:
Electrophysiology, Canada, Revenue ($ m) by Segment, Historic, 2000-2008
117
Table 71: Electrophysiology, Canada, Revenue ($ m) by Segment,
Forecast, 2008-2015 118
Table 72: Electrophysiology, Canada, Volume
(Units) by Segment, Historic, 2000-2008 119
Table 73:
Electrophysiology, Canada, Volume (Units) by Segment, Forecast, 2008-2015
119
Table 74: Electrophysiology, Canada, Average Price ($), Historic,
2000-2008 120
Table 75: Electrophysiology, Canada, Average Price ($),
Forecast, 2008-2015 121
Table 76: Electrophysiology, Canada,
Distribution Share by Revenue ($m), 2007-2008 121
Table 77:
Electrophysiology, Canada, Company Share by Revenue ($ m), 2007-2008 122
Table 78: Interventional Cardiology, Canada, Revenue ($ m) by Segment ,
Historic, 2000-2008 124
Table 79: Interventional Cardiology, Canada,
Revenue ($ mn) by Segment , Forecast, 2008-2015 125
Table 80: Cardiac
Catheter, Canada, Revenue ($ m) by Sub-Segment, Historic, 2000-2008 127
Table 81: Cardiac Catheter, Canada, Revenue ($ m) by Sub-Segment,
Forecast, 2008-2015 128
Table 82: Coronary Stent, Canada, Revenue ($
m) by Sub-Segment, Historic, 2000-2008 129
Table 83: Coronary Stent,
Canada, Revenue ($ m) by Sub-Segment, Forecast, 2008-2015 130
Table 84:
PTCA Balloon, Canada, Revenue ($ m) by Sub-Segment, Historic, 2000-2008
131
Table 85: PTCA Balloon, Canada, Revenue ($ m) by Sub-Segment,
Forecast, 2008-2015 132
Table 86: Interventional Cardiology, Canada,
Volume (Units) by Segment, Historic, 2000-2008 133
Table 87:
Interventional Cardiology, Canada, Volume (Units) by Segment, Forecast,
2008-2015 134
Table 88: Cardiac Catheter, Canada, Volume (Units) by
Sub-Segment, Historic, 2000-2008 135
Table 89: Cardiac Catheter,
Canada, Volume (Units) by Sub-Segment, Forecast, 2008-2015 136
Table 90:
Coronary Stent, Canada, Volume (Units) by Sub-Segment, Historic, 2000-2008
137
Table 91: Coronary Stent, Canada, Volume (Units) by Sub-Segment,
Forecast, 2008-2015 138
Table 92: PTCA Balloon, Canada, Volume
(Units) by Sub-Segment, Historic, 2000-2008 139
Table 93: PTCA
Balloon, Canada, Volume (Units) by Sub-Segment, Forecast, 2008-2015 140
Table 94: Interventional Cardiology, Canada, Average Price ($), Historic,
2000-2008 142
Table 95: Interventional Cardiology, Canada, Average
Price ($), Forecast, 2008-2015 143
Table 96: Interventional
Cardiology, Canada, Distribution Share by Revenue ($mn), 2007-2008 143
Table 97: Interventional Cardiology, Canada, Company Share by Revenue ($
mn), 2007-2008 144
Table 98: Peripheral Vascular Devices, Canada,
Revenue ($ m) by Segment, Historic, 2000-2008 146
Table 99:
Peripheral Vascular Devices, Canada, Revenue ($ m) by Segment, Forecast,
2008-2015 148
Table 100: Peripheral Vascular Devices, Canada, Volume
(Units) by Segment, Historic, 2000-2008 150
Table 101: Peripheral
Vascular Devices, Canada, Volume (Units) by Segment, Forecast, 2008-2015
152
Table 102: Peripheral Vascular Devices, Canada, Average Price
($), Historic, 2000-2008 154
Table 103: Peripheral Vascular Devices,
Canada, Average Price ($), Forecast, 2008-2015 154
Table 104:
Peripheral Vascular Devices, Canada, Distribution Share by Revenue ($m),
2007-2008 155
Table 105: Peripheral Vascular Devices, Canada, Company
Share by Revenue ($ m), 2007-2008 156
Table 106: Boston Scientific
Corporation Pipeline Products by Equipment Type 160
Table 107: Boston
Scientific Corporation Pipeline Products by Development Stage 161
Table
108: Boston Scientific Corporation Pipeline Products by Therapy Area
162
Table 109: Boston Scientific Corporation Pipeline Products by
Clinical Trials 163
Table 110: Boston Scientific Corporation Pipeline
Products by News Summaries 164
Table 111: Medtronic, Inc. Pipeline
Products by Equipment Type 168
Table 112: Medtronic, Inc. Pipeline
Products by Development Stage 169
Table 113: Medtronic, Inc. Pipeline
Products by Therapy Area 171
Table 114: Medtronic, Inc. Pipeline
Products by Clinical Trials 172
Table 115: Medtronic, Inc. Pipeline
Products by News Summaries 173
Table 116: Cordis Corporation Pipeline
Products by Equipment Type 175
Table 117: Cordis Corporation Pipeline
Products by Development Stage 175
Table 118: Cordis Corporation
Pipeline Products by Therapy Area 176
Table 119: Cordis Corporation
Pipeline Products by Clinical Trials 176
Table 120: Cordis
Corporation Pipeline Products by News Summaries 176
Table 121: St.
Jude Medical Inc. Pipeline Products by Equipment Type 182
Table 122:
St. Jude Medical Inc. Pipeline Products by Development Stage 183
Table
123: St. Jude Medical Inc. Pipeline Products by Therapy Area 183
Table 124: St. Jude Medical Inc. Pipeline Products by Clinical Trials
184
Table 125: St. Jude Medical Inc. Pipeline Products by News
Summaries 184
Table 126: BIOTRONIK GmbH & Co. KG Pipeline Products by
Equipment Type 185
Table 127: BIOTRONIK GmbH & Co. KG Pipeline
Products by Development Stage 185
Table 128: BIOTRONIK GmbH & Co. KG
Pipeline Products by Therapy Area 186
Table 129: BIOTRONIK GmbH & Co.
KG Pipeline Products by Clinical Trials 186
Table 130: BIOTRONIK GmbH
& Co. KG Pipeline Products by News Summary 186
Table 131: Philips
Medical Systems Pipeline Products by Equipment Type 190
Table 132:
Philips Medical Systems Pipeline Products by Development Stage 191
Table
133: Philips Medical Systems Pipeline Products by Therapy Area 191
Table 134: Philips Medical Systems Pipeline Products by Clinical Trials
192
Table 135: Philips Medical Systems Pipeline Products by News
Summary 192
Table 136: Edwards Lifesciences Corporation Pipeline
Products by Equipment Type 203
Table 137: Edwards Lifesciences
Corporation Pipeline Products by Development Stage 204
Table 138:
Edwards Lifesciences Corporation Pipeline Products by Therapy Area 204
Table 139: Edwards Lifesciences Corporation Pipeline Products by Clinical
Trials 205
Table 140: Edwards Lifesciences Corporation Pipeline
Products by News Summary 205
Table 141: Thoratec Corporation Pipeline
Products by Equipment Type 208
Table 142: Thoratec Corporation
Pipeline Products by Development Stage 209
Table 143: Thoratec
Corporation Pipeline Products by Therapy Area 209
Table 144: Thoratec
Corporation Pipeline Products by Clinical Trials 209
Table 145:
Thoratec Corporation Pipeline Products by News Summary 209
Table 146:
Arrow International, Inc. Pipeline Products by Equipment Type 215
Table
147: Arrow International, Inc. Pipeline Products by Development Stage
215
Table 148: Arrow International, Inc. Pipeline Products by Therapy
Area 216
Table 149: Arrow International, Inc. Pipeline Products by
Clinical Trials 216
Table 150: ABIOMED, Inc. Pipeline Products by
Equipment Type 219
Table 151: ABIOMED, Inc. Pipeline Products by
Development Stage 219
Table 152: ABIOMED, Inc. Pipeline Products by
Therapy Area 220
Table 153: ABIOMED, Inc. Pipeline Products by
Clinical Trials 220
Table 154: ABIOMED, Inc. Pipeline Products by
News Summary 220
Table 155: AtriCure, Inc. Pipeline Products by
Equipment Type 222
Table 156: AtriCure, Inc. Pipeline Products by
Development Stage 222
Table 157: AtriCure, Inc. Pipeline Products by
Therapy Area 222
Table 158: AtriCure, Inc. Pipeline Products by
Clinical Trials 222
Table 159: AtriCure, Inc. Pipeline Products by
News Summary 223
Table 160: Terumo Corporation Pipeline Products by
Equipment Type 225
Table 161: Terumo Corporation Pipeline Products by
Development Stage 225
Table 162: Terumo Corporation Pipeline Products
by Therapy Area 225
Table 163: Terumo Corporation Pipeline Products
by Clinical Trials 226
Table 164: Terumo Corporation Pipeline
Products by News Summaries 226
Table 165: ev3 Inc. Pipeline Products
by Equipment Type 229
Table 166: ev3 Inc. Pipeline Products by
Development Stage 230
Table 167: ev3 Inc. Pipeline Products by
Therapy Area 230
Table 168: ev3 Inc. Pipeline Products by Clinical
Trials 231
Table 169: ev3 Inc. Pipeline Products by News Summary
231
Table 170: C.R. Bard, Inc. Pipeline Products by Equipment Type
234
Table 171: C.R. Bard, Inc. Pipeline Products by Development Stage
234
Table 172: C.R. Bard, Inc. Pipeline Products by Therapy Area
235
Table 173: C.R. Bard, Inc. Pipeline Products by Clinical Trials
235
Table 174: Interface Biologics, Inc. Pipeline Products by
Equipment Type 237
Table 175: Interface Biologics, Inc. Pipeline
Products by Development Stage 237
Table 176: Interface Biologics,
Inc. Pipeline Products by Therapy Area 238
Table 177: Interface
Biologics, Inc. Pipeline Products by News Summary 238
Table 178:
Kardium Inc. Pipeline Products by Equipment Type 239
Table 179:
Kardium Inc. Pipeline Products by Development Stage 239
Table 180:
Kardium Inc. Pipeline Products by Therapy Area 239
Table 181:
CARDIAnove Pipeline Products by Equipment Type 240
Table 182:
CARDIAnove Pipeline Products by Development Stage 240
Table 183:
CARDIAnove Pipeline Products by Therapy Area 240
Table 184:
CardioComm Solutions Enters Into A Distribution Agreement With Instromedix
241
Table 185: Novadaq Technologies Enters Into An Agreement With
Intuitive Surgical 242
Table 186: USD to Local Currency, Average
Exchange Rate 2008 250
1.2 List of Figures
Figure 1: Healthcare
Financing in Canada, 2004 33
Figure 2: Healthcare Expenditure in Canada,
2000 - 2006 34
Figure 3: Cardiovascular Devices, Canada, Overall
Revenue ($ m), Historic, 2000-2008 46
Figure 4: Cardiovascular
Devices, Canada, Overall Revenue ($ m), Forecast, 2008-2015 48
Figure 5:
Cardiovascular Devices, Canada, Category Volume (Units), Historic,
2000-2008 50
Figure 6: Cardiovascular Devices, Canada, Category
Volume (Units), Forecast, 2008-2015 52
Figure 7: Cardiovascular
Devices, Canada, Cross-Category Analysis, 2000-2015 54
Figure 8:
Cardiovascular Devices, Canada, Company Share (%), 2008 56
Figure 9:
Cardiac Rhythm Management, Canada, Revenue ($ m) by Segment, Historic,
2000-2008 57
Figure 10: Cardiac Rhythm Management, Canada, Revenue ($
m) by Segment, Forecast, 2008-2015 59
Figure 11: Cardiac
Resynchronisation Therapy, Canada, Revenue ($ m) by Sub-Segment, Historic,
2000-2008 60
Figure 12: Cardiac Resynchronisation Therapy, Canada,
Revenue ($ m) by Sub-Segment, Forecast, 2008-2015 61
Figure 13:
Implantable Cardioverter Defibrillator, Canada, Revenue ($ m) by Sub-Segment,
Historic, 2000-2008 63
Figure 14: Implantable Cardioverter
Defibrillator, Canada, Revenue ($ m) by Sub-Segment, Forecast, 2008-2015
64
Figure 15: Pacemaker, Canada, Revenue ($ m) by Sub-Segment,
Historic, 2000-2008 65
Figure 16: Pacemaker, Canada, Revenue ($ m) by
Sub-Segment, Forecast, 2008-2015 66
Figure 17: Cardiac Rhythm
Management, Canada, Volume (Units) by Segment, Historic, 2000-2008 67
Figure 18: Cardiac Rhythm Management, Canada, Volume (Units) by Segment,
Forecast, 2008-2015 68
Figure 19: Cardiac Resynchronisation Therapy,
Canada, Volume (Units) by Sub-Segment, Historic, 2000-2008 69
Figure 20:
Cardiac Resynchronisation Therapy, Canada, Volume (Units) by Sub-Segment,
Historic, 2000-2008 70
Figure 21: Implantable Cardioverter
Defibrillator, Canada, Volume (Units) by Sub-Segment, Forecast, 2008-2015
71
Figure 22: Implantable Cardioverter Defibrillator, Canada, Volume
(Units) by Sub-Segment, Historic, 2000-2008 72
Figure 23: Pacemaker,
Canada, Volume (Units) by Sub-Segment, Forecast, 2008-2015 73
Figure 24:
Pacemaker, Canada, Volume (Units) by Sub-Segment, Forecast, 2008-2015
74
Figure 25: Cardiac Rhythm Management, Canada, Company Share (%),
2008 78
Figure 26: Cardiovascular Monitoring and Diagnostic Devices,
Canada, Revenue ($ m) by Segment, Historic, 2000-2008 79
Figure 27:
Cardiovascular Monitoring and Diagnostic Devices, Canada, Revenue ($ m) by
Segment, Forecast, 2008-2015 81
Figure 28: Cardiovascular Monitoring
and Diagnostic Devices, Canada, Volume (Units) by Segment, Historic, 2000-2008
83
Figure 29: Cardiovascular Monitoring and Diagnostic Devices,
Canada, Volume (Units) by Segment, Forecast, 2008-2015 84
Figure 30:
Cardiovascular Monitoring and Diagnostic Devices, Canada, Company Share (%),
2008 88
Figure 31: Cardiovascular Prosthetic Devices, Canada, Revenue
($ m) by Segment, Historic, 2000-2008 89
Figure 32: Cardiovascular
Prosthetic Devices, Canada, Revenue ($ m) by Segment, Forecast, 2008-2015
91
Figure 33: Cardiac Assist Devices, Canada, Revenue ($ m) by
Sub-Segment, Historic, 2000-2008 93
Figure 34: Cardiac Assist
Devices, Canada, Revenue ($ m) by Sub-Segment, Forecast, 2008-2015 94
Figure 35: Prosthetic Heart Valve, Canada, Revenue ($ m) by Sub-Segment,
Historic, 2000-2008 95
Figure 36: Prosthetic Heart Valve, Canada,
Revenue ($ m) by Sub-Segment, Forecast, 2008-2015 96
Figure 37:
Cardiovascular Prosthetic Devices, Canada, Volume (Units) by Segment,
Historic, 2000-2008 97
Figure 38: Cardiovascular Prosthetic Devices,
Canada, Volume (Units) by Segment, Forecast, 2008-2015 98
Figure 39:
Cardiac Assist Devices, Canada, Volume (Units) by Sub-Segment, Historic,
2000-2008 99
Figure 40: Cardiac Assist Devices, Canada, Volume
(Units) by Sub-Segment, Forecast, 2008-2015 100
Figure 41: Prosthetic
Heart Valve, Canada, Volume (Units) by Sub-Segment, Historic, 2000-2008
101
Figure 42: Prosthetic Heart Valve, Canada, Volume (Units) by
Sub-Segment, Forecast, 2008-2015 102
Figure 43: Cardiovascular
Prosthetic Devices, Canada, Company Share (%), 2008 105
Figure 44:
Cardiovascular Surgery, Canada, Revenue ($ m) by Segment, Historic, 2000-2008
106
Figure 45: Cardiovascular Surgery, Canada, Revenue ($ m) by
Segment, Forecast, 2008-2015 107
Figure 46: Perfusion Disposables,
Canada, Revenue ($ m) by Sub-Segment, Historic, 2000-2008 108
.Figure 47:
Perfusion Disposables, Canada, Revenue ($ m) by Sub-Segment, Forecast,
2008-2015 109
Figure 48: Perfusion Disposables, Canada, Volume
(Units) by Sub-Segment, Historic, 2000-2008 111
Figure 49: Perfusion
Disposables, Canada, Volume (Units) by Sub-Segment, Forecast, 2008-2015
112
Figure 50: Cardiovascular Surgery, Canada, Company Share (%),
2008 116
Figure 51: Electrophysiology, Canada, Revenue ($ m) by
Segment, Historic, 2000-2008 117
Figure 52: Electrophysiology,
Canada, Revenue ($ m) by Segment, Forecast, 2008-2015 118
Figure 53:
Electrophysiology, Canada, Company Share (%), 2008 122
Figure 54:
Interventional Cardiology, Canada, Revenue ($ m) by Segment , Historic,
2000-2008 123
Figure 55: Interventional Cardiology, Canada, Revenue
($ m) by Segment , Forecast, 2008-2015 125
Figure 56: Cardiac
Catheter, Canada, Revenue ($ m) by Sub-Segment, Historic, 2000-2008 126
Figure 57: Cardiac Catheter, Canada, Revenue ($ m) by Sub-Segment,
Forecast, 2008-2015 128
Figure 58: Coronary Stent, Canada, Revenue ($
m) by Sub-Segment, Historic, 2000-2008 129
Figure 59: Coronary Stent,
Canada, Revenue ($ m) by Sub-Segment, Forecast, 2008-2015 130
Figure 60:
PTCA Balloon, Canada, Revenue ($ m) by Sub-Segment, Historic, 2000-2008
131
Figure 61: PTCA Balloon, Canada, Revenue ($ m) by Sub-Segment,
Forecast, 2008-2015 132
Figure 62: Interventional Cardiology, Canada,
Volume (Units) by Segment, Historic, 2000-2008 133
Figure 63:
Interventional Cardiology, Canada, Volume (Units) by Segment, Forecast,
2008-2015 134
Figure 64: Cardiac Catheter, Canada, Volume (Units) by
Sub-Segment, Historic, 2000-2008 135
Figure 65: Cardiac Catheter,
Canada, Volume (Units) by Sub-Segment, Forecast, 2008-2015 136
Figure 66:
Coronary Stent, Canada, Volume (Units) by Sub-Segment, Historic, 2000-2008
137
Figure 67: Coronary Stent, Canada, Volume (Units) by Sub-Segment,
Forecast, 2008-2015 138
Figure 68: PTCA Balloon, Canada, Volume
(Units) by Sub-Segment, Historic, 2000-2008 139
Figure 69: PTCA
Balloon, Canada, Volume (Units) by Sub-Segment, Forecast, 2008-2015 140
Figure 70: Interventional Cardiology, Canada, Company Share (%), 2008
144
Figure 71: Peripheral Vascular Devices, Canada, Revenue ($ m) by
Segment, Historic, 2000-2008 145
Figure 72: Peripheral Vascular
Devices, Canada, Revenue ($ m) by Segment, Forecast, 2008-2015 147
Figure
73: Peripheral Vascular Devices, Canada, Volume (Units) by Segment,
Historic, 2000-2008 149
Figure 74: Peripheral Vascular Devices,
Canada, Volume (Units) by Segment, Forecast, 2008-2015 151
Figure 75:
Peripheral Vascular Devices, Canada, Company Share (%), 2008 156
Figure
76: GlobalData Methodology 246
|
相關報告
|
